Clinical Study | Office of Clinical Research

Randomized Phase III Study Of Focal Radiation Therapy For Unresectable, Localized Intrahepatic Cholangiocarcinoma

Posted Date: May 15, 2019

Investigator: Jordan Kharofa
Type of Study: Drug

There are two usual approaches for treating this type of cancer, chemotherapy (gemcitabine and cisplatin) or radiation therapy. The purpose of this study is to compare any good and bad side effects of using the combination of gemcitabine and cisplatin with the combination of gemcitabine and cisplati

Criteria:

To Be Eligible For This Study, Patients Must Have Intrahepatic Cholangiocarcinoma (A Type Of Liver C

Keywords:

Nrg-Gi001, Icc, Cancer, Unresectable, Intrahepatic Cholang

For More Information:

Uc Cancer Center
513-584-7698
cancer@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List